Product Information
GLIPIZIDE-METFORMIN 5-500 MG is a generic product labeled by Chartwell RX LLC, priced at $0.1961 per EA under NDC 62135073360. Its NADAC has been published 133 times since Dec 13, 2023.
Strength
5; 500 mg/1; mg/1
Manufacturer
Chartwell RX LLCNDC
62135073360
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
GLIPIZIDE; METFORMIN HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA078728On Market Since
6/29/2010
Pharmacological Classes
Price Statistics
The NADAC for GLIPIZIDE-METFORMIN 5-500 MG has been published 133 times since Dec 13, 2023, and over the history we have for it it has declined 31.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1961 per EA |
|---|---|
| All-time high | $0.2850 (Dec 13, 2023) |
| All-time low | $0.1955 (Nov 20, 2024) |
| 52-week high | $0.2224 |
| 52-week low | $0.1961 |
| Median price | $0.2194 |
| Average price | $0.2264 |
| Largest weekly change | -18.3% (Nov 20, 2024) |
| Weeks tracked | 133 |
| Tracking since | Dec 13, 2023 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient, strength, and dosage form. Compare the broader picture on the Glipizide and metformin hcl market page.
Lowest-Cost Alternatives
No alternatives available
Frequently asked questions
What is the NADAC price of GLIPIZIDE-METFORMIN 5-500 MG?
The current National Average Drug Acquisition Cost (NADAC) for GLIPIZIDE-METFORMIN 5-500 MG, manufactured by Chartwell RX LLC, is $0.1961 per EA (NDC 62135073360), effective Jun 24, 2026.
How has the price of GLIPIZIDE-METFORMIN 5-500 MG changed over time?
Over the history we have for it, the NADAC for GLIPIZIDE-METFORMIN 5-500 MG has declined 31.2%. It has been tracked across 133 weekly CMS publications since Dec 13, 2023.
What are the highest and lowest recorded NADAC prices for GLIPIZIDE-METFORMIN 5-500 MG?
Since Dec 13, 2023, the NADAC for GLIPIZIDE-METFORMIN 5-500 MG has ranged from a low of $0.1955 (Nov 20, 2024) to a high of $0.2850 (Dec 13, 2023), with a median of $0.2194 per EA.
Are there cheaper alternatives to GLIPIZIDE-METFORMIN 5-500 MG?
No other NADAC-published product currently shares the active ingredient, strength, and dosage form of GLIPIZIDE-METFORMIN 5-500 MG, so no direct lower-cost alternative is listed.
Who manufactures GLIPIZIDE-METFORMIN 5-500 MG?
GLIPIZIDE-METFORMIN 5-500 MG (NDC 62135073360) is labeled by Chartwell RX LLC, and CMS classifies it as a generic product.
Related Drugs
Same classification